If you have been following business news, especially in the investment management industry, you may have heard that Kerrisdale Capital has published a negative report with respect to biopharmaceutical company Proteostasis Therapeutics. If you’re unfamiliar with Kerrisdale Capital, it is a private investment management company headquartered in New York. With regard to Proteostasis Therapeutics, it is a company that works to develop protocols aimed at restoring protein homeostasis in the human body. The negative report published by Kerrisdale Capital points to the company’s short position with QuinStreet, an Internet marketing firm.
Although Kerrisdale Capital is a relatively small investment management firm, they are creating quite a reputation for themselves in the industry, thanks in large part to CEO and Founder Sahm Adrangi. As far as his professional background goes, Sahm Adrangi attended the prestigious Yale University where he earned a B.A. in economics in 2003, before beginning his career with Deutsche Bank, working in the bank’s leveraged finance division. In 2005, in an effort to broaden his career horizon, he joined Chanin Capital Partners, an investment-banking firm with offices in London, New York, and Detroit.
Still eager to sharpen his skills in the financial world, Sahm Adrangi joined Longacre Fund Management, in 2007. In his role with firm, he served as the Chief Financial Analyst, a role that perfectly aligned with his ambitions and desire to achieve greater professional success. This position enabled Sahm Adrangi to gain a great deal of experience in managing multi-million dollar portfolios. In fact, while with Longacre Fund Management, he was tasked with managing over $2 billion dollars in distressed securities.
What does Kerrisdale Capital hope to gain by publishing negative reports concerning Proteostasis Therapeutics? The firm has made a name for themselves by expertly forecasting company stock performance to build capital. So, more likely than not, that is the chief objective.
The firm’s business model works by investing in troubled companies with the hopes of turning a profit. Basically, the firm will sell stocks that they do not own, expecting that the security price will fall. If it does, the firm is able to repurchase it at a much lower price point and resell them when the security price increases.
Paul Mampilly is the founder of CAPUCHIN CONSULTING
- 1986-1991-He completed his graduation (BBA) in Finance and accounting from Montclair State University
- 1995-1997-He completed his MBA in finance from Fordham Graduate School of Business
There is a famous saying that “It doesn’t matter how many resources you have ,until you know how to utilize it efficiently”.The best live example of this, is the story of an American Investor Paul Mampilly who made the good use of his education to excel in the finance sector. Before completing his MBA from Fordham University he started to work as assistant portfolio managers for the banker’s trust.Due to his excellence in finance sector he earned several important positions at many legal firms.Seeing The capability of Paul Mampilly he was hired by a Billion dollar company.
The main phase of his life started when he left the work at Wall Street where he was helping the rich people to become more richer.He started his own business where he aspired to help and guide the common people. Through his trading service he invested his as well as other’s money to gain the profit. His advice and the knowledge of investment attracted many individuals and hence as a result, he has over 60k subscribers.In one of the interview he said that “He works to satisfy the clients” on being asked about the thing which made him successful and that’s the reason why he touched the peak point of his field.
One line which could be inspirational to anyone, belonging to any field, as said by him “Always try to search for the ways which could go wrong” and this observation helps him to take the correct decision.He also told that always try to think from the other’s point of view which would provide the helpful insight about the situation whereas having a tunnel’s view will always end up on the loosing sideThe work experience of Paul Mampilly shows that he has achieved many things in his life as a professional.
- February 2015-December 2015-He was the author and the analyst at
- March 2014-January 2015-He was the author, investment director
and analyst of FDA at Agora Financial
- October 2011-December 2012-He was the author and the analyst at Palm
Beach Research Group
- September 2006-September 2011-He was the senior portfolio manager at
Kinetics Asset Management.
Because of his Investment skills and mastery in finance, he was able to win the prestigious Templetion foundation Investment Competition.